ARGX
Price
$919.21
Change
-$16.79 (-1.79%)
Updated
Oct 2 closing price
Capitalization
60.12B
20 days until earnings call
Intraday BUY SELL Signals
EXUS
Price
$28.15
Change
+$0.32 (+1.15%)
Updated
Oct 2 closing price
Net Assets
95.52M
Intraday BUY SELL Signals
Interact to see
Advertisement

ARGX vs EXUS

ARGX vs EXUS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ARGX vs. EXUS commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARGX is a StrongBuy and EXUS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ARGX: Fundamental Ratings
ARGX
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
17
SMR RATING
1..100
41
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
36
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARGXEXUS
RSI
ODDS (%)
Bearish Trend 3 days ago
57%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
58%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 16 days ago
73%
Bullish Trend 16 days ago
90%
Declines
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
64%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (ARGX: $936.00)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARGX’s FA Score shows that 1 FA rating(s) are green while .

  • ARGX’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARGX’s TA Score shows that 3 TA indicator(s) are bullish.

  • ARGX’s TA Score: 3 bullish, 6 bearish.

Price Growth

ARGX (@Biotechnology) experienced а -2.72% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

ARGX is expected to report earnings on Oct 22, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ARGX
Daily Signal:
Gain/Loss:
EXUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ETN437.287.57
+1.76%
Eaton Corp
CZR29.62-0.03
-0.10%
Caesars Entertainment
CAN0.34N/A
-1.45%
Canaan
ZONE0.13N/A
-2.39%
CleanCore Solutions
BRUN15.89-0.61
-3.70%
Boost Run Inc

EXUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EXUS has been loosely correlated with ASML. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if EXUS jumps, then ASML could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EXUS
1D Price
Change %
EXUS100%
-0.67%
ASML - EXUS
63%
Loosely correlated
-0.18%
HDB - EXUS
37%
Loosely correlated
+2.73%
MELI - EXUS
23%
Poorly correlated
-2.51%
ASND - EXUS
22%
Poorly correlated
-0.23%
ARGX - EXUS
22%
Poorly correlated
-2.39%
More